Management of hyperglycemia in patients with type 2 diabetics: a strategy centered on the patient Position of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

被引:0
|
作者
不详
机构
关键词
DIPEPTIDYL PEPTIDASE-4 INHIBITORS; IMPAIRED GLUCOSE-TOLERANCE; COMPARING INSULIN DETEMIR; INCRETIN-BASED THERAPIES; LIFE-STYLE MODIFICATION; GLYCEMIC CONTROL; COMBINATION THERAPY; CLINICAL-TRIAL; HEART-FAILURE; BETA-CELL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:AR5 / AR27
页数:23
相关论文
共 50 条
  • [41] Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan, David M.
    Buse, John B.
    Davidson, Mayer B.
    Ferrannini, Ele
    Holman, Rury R.
    Sherwin, Robert
    Zinman, Bernard
    DIABETES CARE, 2009, 32 (01) : 193 - 203
  • [42] Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan, David M.
    Buse, John B.
    Davidson, Mayer B.
    Heine, Robert J.
    Holman, Rury R.
    Sherwin, Robert
    Zinman, Bernard
    DIABETES CARE, 2006, 29 (08) : 1963 - 1972
  • [43] Comment on the consensus report on the management of hyperglycaemia in Type 2 diabetes by the American Diabetes Association and the European Association for the Study of Diabetes
    Skinner, T.
    Byrne, M.
    Dickinson, J. K.
    Fisher, L.
    Funnell, M.
    Guzman, S.
    Hendrieckx, C.
    Hermanns, N.
    Kanc, K.
    Lloyd, C.
    Mocan, A.
    Nouwen, A.
    Pouwer, F.
    Saleh-Stattin, N.
    Snoek, F.
    Speight, J.
    Sturt, J.
    Vallis, M.
    Wagner, J.
    Willaing, I.
    Young-Hyman, D.
    Zoffmann, V.
    DIABETIC MEDICINE, 2019, 36 (07) : 911 - 912
  • [44] Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
    Fleming, G. Alexander
    Petrie, John R.
    Bergenstal, Richard M.
    Holl, Reinhard W.
    Peters, Anne L.
    Heinemann, Lutz
    DIABETOLOGIA, 2020, 63 (02) : 229 - 241
  • [45] Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
    G. Alexander Fleming
    John R. Petrie
    Richard M. Bergenstal
    Reinhard W. Holl
    Anne L. Peters
    Lutz Heinemann
    Diabetologia, 2020, 63 : 229 - 241
  • [46] Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
    Fleming, G. Alexander
    Petrie, John R.
    Bergenstal, Richard M.
    Holl, Reinhard W.
    Peters, Anne L.
    Heinemann, Lutz
    DIABETES CARE, 2020, 43 (01) : 250 - 260
  • [48] The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
    Aschner, Pablo J.
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
  • [49] New ADA/EASD consensus for the management of type 2 diabetes
    Sultan, Ariane
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2018, 22-23 : 252 - 256
  • [50] Management of Hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - Update regarding thiazolidinediones: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan, David M.
    Buse, John B.
    Davidson, Mayer B.
    Ferrannini, Ele
    Holman, Rury R.
    Sherwin, Robert
    Zinman, Bernard
    DIABETES CARE, 2008, 31 (01) : 173 - 175